Cramer: This stock could quadruple By: CNBC.com News July 23, 2014 at 10:57 AM EDT Results of a clinical trial of a breast cancer drug could make this company a takeover target, too, says CNBC's Jim Cramer. Read More >> Related Stocks: Gsk Plc ADR